In April 2024, Dr.Ci:Labo, a skincare brand originating from the medical clinic industry, held a Super Radiant White Appreciation Event in Shanghai, launching its newly upgraded second-generation 377 Super Radiant Bottle.
The "Zhenxianghui" event was held at the Dr.Ci:Labo Skin Management Center in Shanghai. Lei Yuting, Head of Dr.Ci:Labo's China and Travel Retail Business; Angela Du, Head of R&D for Dr.Ci:Labo Asia Pacific; Mu An, Managing Director of United Beauty Group; Xiang Pi, General Manager of Dr.Ci:Labo Brand Department of Shuiyang Group; Xin Baoyin, Deputy General Manager of Shanghai Seoul Beauty; Yu Sheng, General Manager of Shanghai United Beauty; Professor Zheng Quan, Yang Rui, and Dr. Xu Xiaoke, all dermatologists, attended the event and witnessed the brand's launch of a new era of radiant whitening.
Ultra-Radiant White Technology, specially formulated for Asian skin.
As consumers' demands for skin whitening continue to rise, they not only crave improved whitening effects but also expect to prevent dullness and yellowing, and enhance skin radiance. However, most existing products in the industry, relying solely on melanin inhibition, are no longer sufficient to meet these advanced requirements. Addressing this pain point, Dr. Ci:Labo, through years of technological research, has incorporated innovative Super Radiance Whitening Technology into its new Dr. Ci:Labo 2nd Generation 377 Super Radiance Serum, leading the industry to break through the limitations of traditional skin whitening.
Research has found that inhibiting melanin production requires not only suppressing tyrosinase activity at its source, but also proactively intercepting stress and oxidation signals. Replenishing and strengthening collagen can also make skin more radiant and firm. Dr. Ci:Labo's second-generation 377 Ultra Brightening Serum continues the brand's masterful use of its star ingredient, W377, to inhibit melanin production at its source. Building on this, the brand has further upgraded the formula, adding the patented SymVital and SymBright technologies to BV-3X GLOW, which not only reduces stress and oxidation but also slows collagen loss. Simultaneously, it works synergistically with Pro-VC to stimulate collagen regeneration. Compared to the first-generation 377 serum, it offers significant improvements in its mechanisms of action across three dimensions: brightening, radiance, and firmness, providing comprehensive care for radiant, healthy skin.
Angela Du, Head of R&D for Asia Pacific at Dr.Ci:Labo, stated, “For many years, Dr.Ci:Labo has focused on the pigmentation problems and whitening needs of Asian skin, committed to providing more effective whitening solutions tailored to Asian consumers through innovative technology. Before applying BV-3X GLOW’s ultra-bright whitening technology to our products, we conducted over 3,000 efficacy evaluations and tested the 377 series products on more than 500 Asian women, accumulating 15 years of research. This technology directly targets three major melanin targets: tyrosinase, stress signals, and oxidation signals, achieving radiant white skin through a multi-pronged approach.”
Medical aesthetics experts collaborated to decode and launch a "personalized" skin management solution.
From its inception, Dr. Ci:Labo has maintained its medical aesthetic DNA. In 1995, Dr. Yoshinori Ci:Labo founded the first Dr. Ci:Labo Beauty Clinic in Tokyo. The brand is dedicated to researching the characteristics of Asian skin and developing products to complement professional-grade treatments, advocating the philosophy that "professional-grade treatments should be an integral part of daily skincare, rather than a means to temporarily change the condition of the skin."
Combining customized products with customized projects, Dr.Ci:Labo has created a full-cycle skincare system that integrates medical aesthetics technology into daily skincare, providing consumers with streamlined, high-efficiency, and scientific "personalized" skin management solutions.
This time, Dr.Ci:Labo is also applying its SuperRadiance White technology to its professional skincare line. Dr.Ci:Labo Medical Aesthetics Clinic in Beijing is simultaneously launching a 377-named professional skincare project – the SuperRadiance White project – offering a complete and efficient one-stop solution to help consumers maintain radiant and glowing skin. At the same time, doctors at Dr.Ci:Labo Medical Aesthetics Clinic in Beijing are sharing the results of using the IPL skin rejuvenation treatment with the 377 SuperRadiance Bottle, based on in-house testing of the SuperRadiance White project, contributing to industry insights and innovation.
Both Professor Zheng Quan, a dermatology expert, and Dr. Xu Xiaoke, a dermatology professional, pointed out that as consumers' demand for phototherapy and optoelectronic treatments increases, post-treatment care is often neglected. A scientific and effective care plan will help with post-treatment recovery.
Combining scientific evidence with technological innovation, Dr. Ci:Labo is committed to empowering consumers' skin management through its professional expertise. The launch of the second-generation 377 Ultra-Light Bottle and related professional skincare programs demonstrates Dr. Ci:Labo's outstanding exploration in the field of radiant skin. As a professional-grade skincare brand, Dr. Ci:Labo will remain dedicated to deepening its expertise in dermatology, providing beauty seekers with more cutting-edge solutions to skin problems.
